A double-blind, randomized, placebo-controlled, multicenter 4-week study to assess the effect of alendronate 70 mg and vitamin D3 2800 IU once weekly on fractional calcium absorption in postmenopausal osteoporotic women

Trial Profile

A double-blind, randomized, placebo-controlled, multicenter 4-week study to assess the effect of alendronate 70 mg and vitamin D3 2800 IU once weekly on fractional calcium absorption in postmenopausal osteoporotic women

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Jan 2015

At a glance

  • Drugs Alendronic acid/colecalciferol (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Pharmacodynamics
  • Sponsors Merck & Co; Merck Sharp & Dohme
  • Most Recent Events

    • 01 Aug 2011 Results published in the Journal of Bone and Mineral Research.
    • 11 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top